MUFG Americas Holdings Corp decreased its position in Clorox Company (The) (NYSE:CLX) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,429 shares of the company’s stock after selling 445 shares during the quarter. MUFG Americas Holdings Corp’s holdings in Clorox were worth $1,244,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Willis Investment Counsel boosted its holdings in shares of Clorox by 2.3% in the 3rd quarter. Willis Investment Counsel now owns 56,720 shares of the company’s stock worth $7,482,000 after purchasing an additional 1,300 shares during the period. USS Investment Management Ltd boosted its holdings in shares of Clorox by 14.1% in the 3rd quarter. USS Investment Management Ltd now owns 53,500 shares of the company’s stock worth $7,056,000 after purchasing an additional 6,600 shares during the period. Pittenger & Anderson Inc. boosted its holdings in shares of Clorox by 26.4% in the 3rd quarter. Pittenger & Anderson Inc. now owns 29,640 shares of the company’s stock worth $3,910,000 after purchasing an additional 6,185 shares during the period. Investment Centers of America Inc. boosted its holdings in shares of Clorox by 11.4% in the 3rd quarter. Investment Centers of America Inc. now owns 11,830 shares of the company’s stock worth $1,558,000 after purchasing an additional 1,207 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its holdings in shares of Clorox by 3.5% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 638,268 shares of the company’s stock worth $84,194,000 after purchasing an additional 21,570 shares during the period. 73.39% of the stock is currently owned by institutional investors and hedge funds.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is currently owned by corporate insiders.

A number of brokerages have recently commented on CLX. Jefferies Group reiterated a “hold” rating and issued a $137.00 target price (up previously from $136.00) on shares of Clorox in a report on Wednesday, August 9th. Barclays restated an “equal weight” rating and set a $136.00 price objective (down previously from $140.00) on shares of Clorox in a report on Friday, August 4th. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a report on Monday, November 6th. BMO Capital Markets restated a “buy” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, October 5th. Finally, Consumer Edge upgraded Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $128.72.

Clorox Company (NYSE:CLX) opened at $139.64 on Friday. Clorox Company has a 1-year low of $113.01 and a 1-year high of $141.76. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. The stock has a market capitalization of $17,963.73, a price-to-earnings ratio of 25.10, a P/E/G ratio of 3.80 and a beta of 0.42.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.05. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the business earned $1.36 EPS. Clorox’s revenue was up 4.0% compared to the same quarter last year. equities analysts expect that Clorox Company will post 5.58 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be issued a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 2.41%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio is 61.88%.

WARNING: “MUFG Americas Holdings Corp Trims Holdings in Clorox Company (The) (CLX)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/12/02/mufg-americas-holdings-corp-trims-holdings-in-clorox-company-the-clx.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.